Dupixent Dangers Drive Growing Cancer Lawsuits
We are investigating a growing number of lawsuits involving Dupixent (dupilumab), a widely used drug prescribed for eczema, asthma, and other allergic conditions. As more patients come forward, these cases are raising concerns about a possible link between Dupixent and a rare cancer called cutaneous T-cell lymphoma (CTCL). One recent lawsuit filed in federal court […]











